NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+2.09%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.37B
AUM Growth
+$1.37B
(-14%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-12.73%
Top 10 Holdings %
Top 10 Hldgs %
17.96%
Holding
225
New
21
Increased
69
Reduced
53
Closed
28
Top Buys
| 1 |
Ginkgo Bioworks
DNA
|
$27.6M |
| 2 |
MaxCyte
MXCT
|
$12M |
| 3 |
The Beauty Health Co
SKIN
|
$10.3M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$8.57M |
| 5 |
Alpha Teknova
TKNO
|
$7.75M |
Top Sells
| 1 |
Zai Lab
ZLAB
|
$25.1M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$22.5M |
| 3 |
Inspire Medical Systems
INSP
|
$21.2M |
| 4 |
10x Genomics
TXG
|
$21.1M |
| 5 |
Repligen
RGEN
|
$13.9M |
Sector Composition
| 1 | Healthcare | 35.81% |
| 2 | Technology | 14.81% |
| 3 | Financials | 9.02% |
| 4 | Industrials | 8.86% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insulet
PODD
$23.9B
| $14.2M | 1.04% | 50,100 -21,654 | -30% | -$6.15M |
|
27
Kontoor Brands
KTB
$4.29B
| $13.7M | 1% | 274,124 +4,067 | +2% | +$203K |
|
|
EXE
28
Expand Energy Corporation Common Stock
EXE
$23B
| $13.5M | 0.99% | 219,545 +139,212 | +173% | +$8.57M |
|
29
BridgeBio Pharma
BBIO
$9.89B
| $13.4M | 0.98% | 286,132 -165,850 | -37% | -$7.77M |
|
30
Krystal Biotech
KRYS
$4.27B
| $13.4M | 0.98% | 256,875 -56,579 | -18% | -$2.95M |
|
31
Veeva Systems
VEEV
$44B
| $13.3M | 0.97% | 46,243 -23,367 | -34% | -$6.73M |
|
32
Goldman Sachs
GS
$226B
| $13.2M | 0.97% | 35,000 -17,961 | -34% | -$6.79M |
|
|
AMRS
33
DELISTED
Amyris Inc.
AMRS
| $13M | 0.95% | 946,366 -302,412 | -24% | -$4.15M |
|
|
FRC
34
DELISTED
First Republic Bank
FRC
| $13M | 0.95% | 67,358 +11,391 | +20% | +$2.2M |
|
|
DMTK
35
DELISTED
DermTech, Inc. Common Stock
DMTK
| $12.9M | 0.94% | 400,308 +34,375 | +9% | +$1.1M |
|
36
Bank of America
BAC
$376B
| $12.7M | 0.93% | 300,000 +30,000 | +11% | +$1.27M |
|
37
Ares Management
ARES
$39.3B
| $12.6M | 0.92% | 170,000 | – | – |
|
38
Exxon Mobil
XOM
$487B
| $12.4M | 0.9% | 210,000 -5,000 | -2% | -$294K |
|
39
Caesars Entertainment
CZR
$5.57B
| $12.3M | 0.9% | 109,572 +118 | +0.1% | +$13.2K |
|
40
Instil Bio
TIL
$182M
| $12.1M | 0.89% | 679,171 -173,648 | -20% | -$3.1M |
|
|
41
MaxCyte
MXCT
$148M
| $12M | 0.87% | +980,122 | New | +$12M |
|
42
BILL Holdings
BILL
$4.72B
| $11.9M | 0.87% | 44,687 +2,694 | +6% | +$719K |
|
|
ARNA
43
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $11.9M | 0.87% | 199,410 -98,837 | -33% | -$5.89M |
|
44
Guardant Health
GH
$8.41B
| $11.8M | 0.86% | 94,363 -32,860 | -26% | -$4.11M |
|
|
OSH
45
DELISTED
Oak Street Health, Inc.
OSH
| $11.8M | 0.86% | 276,596 -106,794 | -28% | -$4.54M |
|
46
Exact Sciences
EXAS
$8.98B
| $11.3M | 0.82% | 118,259 -54,909 | -32% | -$5.24M |
|
47
Chevron
CVX
$324B
| $11.2M | 0.81% | 110,000 | – | – |
|
48
Schrodinger
SDGR
$1.44B
| $11M | 0.8% | 201,513 -67,681 | -25% | -$3.7M |
|
49
Topgolf Callaway Brands
MODG
$1.76B
| $11M | 0.8% | 398,539 -93,075 | -19% | -$2.57M |
|
50
FIVE9
FIVN
$2.08B
| $10.5M | 0.76% | 65,518 +2,370 | +4% | +$379K |
|